Merck KGaA (MKGAF)
(Delayed Data from OTC)
$189.80 USD
+2.83 (1.52%)
Updated Aug 15, 2024 03:56 PM ET
4-Sell of 5 4
A Value C Growth C Momentum B VGM
Cash flow Statements
Fiscal Year End for Merck KGaA falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 3,067.24 | 3,517.97 | 3,626.20 | 2,277.75 | 1,482.88 |
Depreciation/Amortization & Depletion | 2,034.72 | 2,138.81 | 2,084.62 | 2,213.78 | 2,177.28 |
Net Change from Assets/Liabilities | -765.19 | -1,140.00 | -324.17 | -451.21 | -456.96 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -240.27 | -28.45 | 73.35 | -67.40 | -4.48 |
Net Cash From Operating Activities | 4,095.42 | 4,487.28 | 5,461.19 | 3,971.78 | 3,198.72 |
Property & Equipment | -1,935.15 | 22.13 | -1,252.90 | -1,574.09 | -875.84 |
Acquisition/ Disposition of Subsidiaries | -12.99 | -632.16 | -4.73 | -12.57 | -5,622.40 |
Investments | -29.22 | -980.90 | -236.62 | 70.82 | -62.72 |
Other Investing Activities | -68.18 | -1,298.04 | -372.68 | -15.99 | -329.28 |
Net Cash from Investing Activities | -2,047.71 | -2,890.03 | -1,866.93 | -1,530.68 | -6,891.36 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | -614.75 | -619.52 | -2,066.88 | -953.82 | 2,901.92 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -1,259.80 | -1,017.78 | -894.42 | -784.76 | -771.68 |
Other Financing Activities | 0.00 | -11.59 | -9.47 | -8.00 | -13.44 |
Net Cash from Financing Activities | -1,874.54 | -1,638.35 | -2,962.48 | -1,738.58 | 2,130.24 |
Effect of Exchange Rate Changes | -33.55 | -7.38 | 10.65 | -45.69 | 5.60 |
Net Change In Cash & Equivalents | 138.53 | -47.41 | 643.61 | 655.68 | -1,555.68 |
Cash at Beginning of Period | 2,006.58 | 2,000.79 | 1,603.10 | 892.14 | 2,430.40 |
Cash at End of Period | 2,145.12 | 1,953.37 | 2,246.71 | 1,547.82 | 874.72 |
Diluted Net EPS | 7.02 | 8.06 | 8.32 | 5.22 | 3.40 |
Fiscal Year End for Merck KGaA falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | 758.90 | 3,067.24 | 2,444.55 | 1,642.14 |
Depreciation/Amortization & Depletion | NA | 492.91 | 2,034.72 | 1,494.37 | 1,022.80 |
Net Change from Assets/Liabilities | NA | -112.91 | -765.19 | -762.97 | -915.94 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | -14.11 | -240.27 | -204.62 | -140.66 |
Net Cash From Operating Activities | NA | 1,123.70 | 4,095.42 | 2,972.42 | 1,608.34 |
Property & Equipment | NA | -555.88 | -1,935.15 | -1,390.98 | -932.29 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | -12.99 | -9.80 | 0.00 |
Investments | NA | 282.28 | -29.22 | 371.14 | 254.06 |
Other Investing Activities | NA | -473.37 | -68.18 | -538.76 | -512.49 |
Net Cash from Investing Activities | NA | -748.05 | -2,047.71 | -1,568.38 | -1,189.63 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | NA | -59.71 | -614.75 | 441.89 | 770.91 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | -56.46 | -1,259.80 | -1,265.81 | -1,267.05 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | -116.17 | -1,874.54 | -825.01 | -497.22 |
Effect of Exchange Rate Changes | NA | -2.17 | -33.55 | -20.68 | -22.90 |
Net Change In Cash & Equivalents | NA | 258.40 | 138.53 | 556.17 | -101.41 |
Cash at Beginning of Period | NA | 2,151.86 | 2,006.58 | 2,017.89 | 2,021.60 |
Cash at End of Period | NA | 2,410.25 | 2,145.12 | 2,574.07 | 1,920.19 |
Diluted Net EPS | 1.51 | 1.74 | 1.44 | 1.85 | 1.77 |